Tinea Pedis
📧 Sign up to get email alerts when something new happens for Tinea Pedis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: A Therapeutic Equivalence Study of Ketoconazole Cream 2% [Phase 3]
Phase 3 therapeutic equivalence trial of Ketoconazole Cream 2% for tinea pedis completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Non-inferiority Trial of Dapaconazole Versus Ketoconazole [Phase 3]
Phase 3 non-inferiority trial comparing dapaconazole to ketoconazole for tinea pedis has completed.
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental approval for the clotrimazole and betamethasone dipropionate topical product. The action approves…
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for clotrimazole and betamethasone dipropionate topical from NorthStar RX LLC.
-
FDA approval · 2020-05-29FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved a supplemental application for clotrimazole and betamethasone dipropionate from Glenmark Pharmaceuticals USA, authorizing an up…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2020-04-09FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc. to update the product labeling.
-
FDA approval · 2019-12-03FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for naftifine hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA label_change · 2019-12-03FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for naftifine hydrochloride from Sun Pharmaceutical Industries, Inc., updating the labeling for …
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris [Phase 4]
A Phase 4 clinical trial update evaluating maximal use of luliconazole 1% cream in children with moderate to severe tinea pedis or tinea cru…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris [Phase 4]
Phase 4 clinical trial evaluating drug interaction potential of luliconazole 1% cream in participants with tinea pedis and tinea cruris has …
-
FDA label_change · 2019-10-28FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a Sun Pharmaceutical supplemental application for Naftifine Hydrochloride, updating the product labeling for the topical antifu…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot [Phase 2]
Phase 2 clinical trial evaluating a nitric oxide releasing footbath for treating athlete's foot (tinea pedis) has completed with results pos…
-
FDA approval · 2019-07-25FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (TruPharma LLC)
FDA approved TruPharma LLC's clotrimazole topical solution 1% as an original application (ANDA) for treatment of common cutaneous fungal inf…
-
FDA approval · 2019-07-18FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) from Karo Healthcare Inc.
-
FDA approval · 2019-07-17FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)
FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) submitted by Voyant Beauty Inc. The approval docume…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS [Phase 2]
Phase 2 clinical trial comparing terbinafine 1% topical solution to butenafine 1% topical solution for treating tinea pedis.
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis [Phase 3]
Phase 3 clinical trial assessing therapeutic equivalence of Ketoconazole Cream 2% for tinea pedis has completed and results are posted.
-
FDA approval · 2019-04-10FDA Approved: NAFTIFINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Naftifine hydrochloride topical from Sun Pharmaceutical Industries under an original ANDA for treating common fungal skin i…
-
FDA approval · 2019-02-15FDA Approved: CLOTRIMAZOLE — Original Application (Novitium Pharma LLC)
FDA approved the original application for clotrimazole topical from Novitium Pharma LLC, a generic topical antifungal.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: SB208 for the Treatment of Tinea Pedis [Phase 2]
Phase 2 clinical trial update for SB208 targeting tinea pedis (athlete's foot) has completed.
-
FDA approval · 2018-10-18FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis [Phase 3]
A Phase 3 trial evaluating therapeutic equivalence and safety of two econazole nitrate cream 1% products for tinea pedis has completed with …
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis [Phase 2]
Phase 2 study evaluating oral VT-1161 for moderate to severe interdigital tinea pedis has completed with results posted in 2018.
-
FDA approval · 2018-06-18FDA Approved: KETOCONAZOLE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for Ketoconazole, a generic antifungal product, covering common dermatophytic an…
-
FDA approval · 2018-05-31FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves the original application for the generic topical combination Nystatin and Triamcinolone Acetonide by Lupin Pharmaceuticals for …